Jing Yu

Ms. Jing Yu

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2025 in Experimental Gerontology
Verified
Journal Article
Open access
XCXi Chen
Xi Chen
YZYingxiao Zhang
Yingxiao Zhang
YZYuxing Zhao
Yuxing Zhao
MZMin Zhou
Min Zhou
PCPan Cheng
Pan Cheng
JYJing Yu
Jing Yu
Ferroptosis has been implicated in skeletal muscle aging. Nevertheless, specific ferroptosis-related genes (FRGs) governing skeletal muscle aging remain unclear. The aim of this study was to identify ferroptosis-related marker genes associated with skeletal muscle aging, uncovering potential therapeutic targets for skeletal muscle aging. Data from GSE38718 was utilized to identify differentially expressed FRGs (DE-FRGs) in aging versus normal human skeletal muscle by the least absolute shrinkage and selection operator (LASSO) and the support vector machine recursive feature elimination (SVM-RFE) algorithms. Validation was conducted using RT-qPCR and Western blot in aging mouse muscle and D-galactose (D-gal)-treated C2C12 cells. SLC38A1 was identified as a significantly downregulated marker for aging skeletal muscle. Overexpression of SLC38A1 mitigated cellular aging in D-gal treated C2C12 cells. In both D-gal treated and sh-SLC38A1 C2C12 cells, increased ROS levels, elevated mtROS, higher intracellular iron concentrations, and intensified lipid peroxidation were observed. In contrast, SLC38A1 overexpression markedly reduced the accumulation of ROS, mtROS, iron concentration, and lipid peroxidation associated with D-gal treatment in these cells. In conclusion, through screening analyses and validation experiments, we identified SLC38A1 as a ferroptosis-related regulator for skeletal muscle aging.

15 October 2025 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
KLKang Luo
Kang Luo
LDLiang Duan
Liang Duan
HHHongyan He
Hongyan He
XHXiaoqian Hu
Xiaoqian Hu
KPKaili Pi
Kaili Pi
QXQian Xiao
Qian Xiao
Evidence indicates that exposure to environmental chemicals may be related to frailty; however, most existing research has focused on single-exposure scenarios. This study aims to systematically evaluate the relationships between multiple environmental toxin exposures and frailty using a comprehensive exposure group approach and to investigate potential mechanisms mediated by systemic inflammation. Data from 2354 participants in the 2013-2016 National Health and Nutrition Examination Survey (NHANES) were analyzed. Environmental toxins were categorized into 10 groups, encompassing 61 substances. Frailty was assessed using a 36-item Frailty Index (FI). We applied an exposure‑wide association study (ExWAS; to screen for individual toxin-frailty associations) and deletion/substitution/addition (DSA; to identify key exposures in multi‑exposure contexts) models, and used Bayesian kernel machine regression (BKMR; to evaluate joint relationships and potential interactions among selected exposures). The role of systemic inflammation was evaluated through mediation analysis. Of the 2354 adults analyzed, 657 (27.9 %) were classified as frailty. ExWAS and DSA models identified total nicotine equivalent-2, tungsten, cobalt, tin, and N-acetyl-S-(2-carboxyethyl)-L-cysteine as significant exposures associated with frailty. BKMR analysis revealed a positive correlation between key exposures and frailty. Mediation analysis indicated that systemic inflammation mediated 2.5-14.6 % of these associations. To our knowledge, this is the first comprehensive study to report associations between three categories of five environmental toxins and frailty in U.S. adults, with inflammation potentially serving as a partial mediator. These findings are critical for identifying hazardous environmental chemicals and developing targeted strategies to promote healthy aging.

26 September 2025
Verified
Dataset
Closed access
PDF file
KLKang Luo
Kang Luo
WXWenjing Xia
Wenjing Xia
YZYingxiao Zhang
Yingxiao Zhang
JYJing Yu
Jing Yu
MZMin Zhou
Min Zhou
LXLingjie Xu
Lingjie Xu
Previous research has yielded inconsistent findings concerning the relationship between serum uric acid (UA) levels and sarcopenia. However, there is currently no research that comprehensively examines this relationship within the broader Chinese population. This study aims to explore the relationship between serum uric acid levels and sarcopenia in Chinese adults aged 45 and above, focusing specifically on age-related variations. The present study involved 10,938 participants of the 2015 China Health and Retirement Longitudinal Study (CHARLS). The associations between sarcopenia (including its components) and serum uric acid levels were evaluated using weighted logistic and weighted linear regression models. After categorizing participants by age groups, the subgroup analysis conducted allowed for a more detailed examination of age-related changes. Participants were stratified into quartiles based on their uric acid levels. Adjusted analyses revealed that a higher serum uric acid level was negatively associated with sarcopenia only in individuals aged 65 and older. Results from weighted linear regression analysis indicated a statistically significant positive correlation between serum uric acid levels and both handgrip strength (HGS) and skeletal muscle index (SMI). Moreover, the Q4 group (≥5.70 mg/dL) sustained this positive correlation across all ages. The results showed that higher UA levels were significantly associated with increased SMI and HGS in Chinese people aged 45 years and older. Elevated levels of blood uric acid may potentially exert a safeguarding influence against the onset of sarcopenia, particularly in individuals aged 65 years and above.